slider

Institutional Investor: Why Biotech Struggles to Finish What It Starts Read more: As more drugs stall between early data and […]

Bausch Health to Acquire DURECT Corporation Read more: Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), a global, diversified pharmaceutical

Sun pharma to acquire checkpoint Therapeutics Read more: for a full summary of the event. Locust Walk co-hosted the third annual

Banyan BioInnovations Read more: Banyan BioInnovations announces its launch as an investment firm that identifies best or first in class